Bill Simpson has an extensive background in psychology, mental health and clinical data analytics. He began academic life as an undergraduate researcher before becoming a research assistant and finally completing his Ph.D in Neurosciences at McMaster University. He has managed data collection and analysis for industry sponsored clinical trials and large international cohort studies. He has 17 peer-reviewed publications covering a range of topics and speaks regularly at Canadian and other international conferences on the digital health revolution, machine learning and apps for mental health. He is currently the Director of Data Science at MEMOTEXT where he spends most of his time working on new algorithms and analytics strategies. He is also a Senior Research Associate at McMaster University where he works on clinical trials for ADHD, understanding if internet addiction is a thing and looking at how marijuana can impact mental health.
As exciting as machine learning's potential is, there is a temptation to apply it way too generously on everything healthcare-related. But there are some important limitations to consider for this technology.
We need a better way forward, one which protects the networks and IP of established eHealth companies, while also enabling active innovation from the eHealth community.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.